Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 5753548; or from the webcast link in the investor relations section of the company’s website at: www.revance.com.
A replay of the call will be available beginning
About
"Revance Therapeutics" and the Revance logo are registered trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20190424005880/en/
Source:
INVESTORS
Revance Therapeutics, Inc.:
Jeanie Herbert,
714-325-3584
jherbert@revance.com
or
Gilmartin
Group, LLC.:
Laurence Watts, 619-916-7620
laurence@gilmartinir.com
or
MEDIA
Nadine Tosk, 504-453-8344
nadinepr@gmail.com